Ranitidine Hcl Injection 50mg/2ml Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50mg/2ml
Reference Brands: Zantac (USA/EU), Rantac (India), Aciloc (india)
Category: Gastrointestinal Drugs
Ranitidine injection is used in people who are hospitalized to treat certain conditions in which the stomach produces too much acid or to treat ulcers (sores in the lining of the stomach or intestine) that were not successfully treated with other medications.
Product Description:
Ranitidine is a histamine H2 receptor antagonist widely used to reduce the production of stomach acid. By blocking H2 receptors in the gastric lining, it effectively decreases acid secretion, helping to relieve symptoms associated with excess stomach acid. It has been commonly prescribed for the treatment of conditions such as peptic ulcer disease, gastroesophageal reflux disease (GERD), and Zollinger–Ellison syndrome.
Ranitidine can be administered through multiple routes, including oral tablets, syrups, and injectable forms such as intramuscular (IM) and intravenous (IV) injections. This flexibility makes it suitable for both outpatient and hospital settings, particularly when rapid acid suppression is required.
The medication works by providing relief from symptoms like heartburn, acid indigestion, and stomach discomfort, while also promoting healing of ulcers in the stomach and intestines. Due to its effectiveness and ease of use, ranitidine was widely utilized across global healthcare systems for many years as a reliable acid-reducing therapy.
However, its use has been significantly restricted or discontinued in many countries due to safety concerns related to impurities, and alternative medications are now more commonly recommended.
Ranitidine Hcl Injection — third party manufacturing & bulk supply
Ranitidine Hcl Injection 50mg/2ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Ranitidine Hcl Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ranitidine Hcl Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ranitidine Hcl Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Ranitidine is used to reduce stomach acid production and treat conditions such as gastric ulcers, duodenal ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome.
Ranitidine is made from Ranitidine Hydrochloride, a compound that blocks histamine H2 receptors in the stomach, thereby reducing acid secretion.
The most common trade name was Zantac, along with Rantac, Aciloc, Histac, and Zinetac in various regions.
Ranitidine was originally developed and marketed under the brand Zantac by GlaxoSmithKline (GSK), with many global and Indian manufacturers producing generic versions.
The generic name is Ranitidine Hydrochloride.
Brand names included Zantac, Rantac, Aciloc, Histac, and Zinetac.
Ranitidine was manufactured globally, including in the USA, Europe, India, and other pharmaceutical manufacturing hubs, though current production depends on regulatory approvals due to safety concerns.
Related Products
Bismuth Subsalicylate
Strength:
262 mg, 525 mg
Form: Oral suspension / Tablet
Reference Brands: Pepto-Bismol (USA/LATAM),
View Details
Quick Response Guaranteed | Verified Suppliers
